Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

BACKGROUND: Docetaxel and gemcitabine combinations have proven active for the treatment of non-small cell lung cancer (NSCLC). The aim of the present study was to evaluate and compare two treatment schedules, one based on our own preclinical data and the other selected from the literature. METHODS:...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Passardi, Alessandro, Cecconetto, Lorenzo, Dall'Agata, Monia, Dazzi, Claudio, Pasquini, Enzo, Oliverio, Giovanni, Zumaglini, Federica, Zoli, Wainer, Nanni, Oriana, Milandri, Carlo, Frassineti, Giovanni Luca, Amadori, Dino
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2008
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2583994/
https://ncbi.nlm.nih.gov/pubmed/18976450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-65
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы